Immunohematology Market - Global Industry Analysis

Immunohematology Market by Product (Immunohematology Analyzer and Immunohematology Reagents), by Application (Blood Typing, Antibody Screening, and Others), and by End-User (Hospitals, Academic and Research Institutes, Blood Banks, and Diagnostics & Reference Laboratories): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 24-Jun-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3820 Status : Published

Global immunohematology market expected to generate around USD 2.29 billion by 2025, at a CAGR of around 4.3% between 2019 and 2025. The growing prevalence of blood cancer and blood-related diseases, such as sickle cell disease, is leading to an increase in the demand for blood transfusion procedures. This, in turn, is fueling the global immunohematology market.

Description

The report covers a forecast and an analysis of the immunohematology market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the immunohematology market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunohematology market on a global level.

In order to give the users of this report a comprehensive view of the immunohematology market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Immunohematology Market

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market.

The study provides a decisive view of the immunohematology market by segmenting it on the basis of product, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players of the global immunohematology market are Thermo Fisher Scientific, Bio-Rad Laboratories, IMMUNOCOR, Siemens Healthineers, Ortho Clinical Diagnostics, Grifols, Beckman Coulter, Becton, Dickinson and Company, Abbott Laboratories, and Merck.

This report segments the global immunohematology market into:

Global Immunohematology Market: Product Analysis

  • Immunohematology Analyzer
  • Immunohematology Reagents

Global Immunohematology Market: Application Analysis

  • Blood Typing
  • Antibody Screening
  • Others

Global Immunohematology Market: End-User Analysis

  • Hospitals
  • Academic and Research Institutes
  • Diagnostics and Reference Laboratories
  • Blood Banks

Global Immunohematology Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global immunohematology market, 2016-2025 (USD Billion)
    • 2.2. Global immunohematology market: Snapshot
  •  
  • Chapter 3. Immunohematology Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global immunohematology market drivers: Impact analysis
      • 3.2.2. The increasing rate of trauma injuries
      • 3.2.3. Industry players introducing new products
      • 3.2.4. Rising prevalence of target diseases
    • 3.3. Market Restraints
      • 3.3.1. Global immunohematology market restraints: Impact analysis
      • 3.3.2. The dearth of trained professionals
      • 3.3.3. High Cost of Products
    • 3.4. Opportunities
      • 3.4.1. Government reimbursement programs in both developed and developing countries
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by product
      • 3.6.2. Market attractiveness analysis, by application
      • 3.6.3. Market attractiveness analysis, by end-user
      • 3.6.4. Market attractiveness analysis, by region
  •  
  • Chapter 4. Global Immunohematology Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global immunohematology market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New instruments launch
      • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
      • 4.2.4. Research and development and regional expansion
  •  
  • Chapter 5. Global Immunohematology Market - Product Analysis
    • 5.1. Global immunohematology market: Product overview
      • 5.1.1. Global immunohematology market revenue share, by product, 2018 and 2025
    • 5.2. Immunohematology Analyzer
      • 5.2.1. Global immunohematology market for immunohematology analyzer, 2016-2025 (USD Billion)
    • 5.3. Immunohematology Reagents
      • 5.3.1. Global immunohematology market for immunohematology reagents, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Immunohematology Market - Application Analysis
    • 6.1. Global immunohematology market: Application overview
      • 6.1.1. Global immunohematology market revenue share, by application, 2018 and 2025
    • 6.2. Blood Typing
      • 6.2.1. Global immunohematology market for blood typing, 2016-2025 (USD Billion)
    • 6.3. Antibody Screening
      • 6.3.1. Global immunohematology market for antibody screening, 2016-2025 (USD Billion)
    • 6.4. Others
      • 6.4.1. Global immunohematology market for others, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Immunohematology Market - End-User Analysis
    • 7.1. Global immunohematology market: End-User overview
      • 7.1.1. Global immunohematology market revenue share, by End-User, 2018 and 2025
    • 7.2. Academic and Research Institutes
      • 7.2.1. Global immunohematology market for academic and research institutes, 2016-2025 (USD Billion)
    • 7.3. Hospitals
      • 7.3.1. Global immunohematology market for hospitals, 2016-2025 (USD Billion)
    • 7.4. Diagnostics & Reference Laboratories
      • 7.4.1. Global immunohematology market for diagnostics & reference laboratories, 2016-2025 (USD Billion)
    • 7.5. Blood banks
      • 7.5.1. Global immunohematology market for blood banks, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Global Immunohematology Market - Regional Analysis
    • 8.1. Global immunohematology market: Regional overview
      • 8.1.1. Global immunohematology market revenue share, by region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America immunohematology market revenue, 2016-2025 (USD Billion)
      • 8.2.2. North America immunohematology market revenue, by product, 2016-2025 (USD Billion)
      • 8.2.3. North America immunohematology market revenue, by application, 2016-2025 (USD Billion)
      • 8.2.4. North America immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.2.5.2. The U.S. immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.2.5.3. The U.S. immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.2.6.2. Canada immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.2.6.3. Canada immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe immunohematology market, 2016-2025 (USD Billion)
      • 8.3.2. Europe immunohematology market revenue, by product, 2016-2025 (USD Billion)
      • 8.3.3. Europe immunohematology market revenue, by application, 2016-2025 (USD Billion)
      • 8.3.4. Europe immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.3.5.2. UK immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.5.3. UK immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.6. Germany
        • 8.3.6.1. Germany immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.3.6.2. Germany immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.6.3. Germany immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.7. France
        • 8.3.7.1. France immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.3.7.2. France immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.7.3. France immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.3.8.2. Rest of Europe immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.3.8.3. Rest of Europe immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific immunohematology market, 2016-2025 (USD Billion)
      • 8.4.2. Asia Pacific immunohematology market revenue, by product, 2016-2025 (USD Billion)
      • 8.4.3. Asia Pacific immunohematology market revenue, by application, 2016-2025 (USD Billion)
      • 8.4.4. Asia Pacific immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.4.5.2. China immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.5.3. China immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.4.6.2. Japan immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.6.3. Japan immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.4.7.2. India immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.7.3. India immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.4.8.2. Rest of Asia Pacific immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.4.8.3. Rest of Asia Pacific immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America immunohematology market, 2016-2025 (USD Billion)
      • 8.5.2. Latin America immunohematology market revenue, by product, 2016-2025 (USD Billion)
      • 8.5.3. Latin America immunohematology market revenue, by application, 2016-2025 (USD Billion)
      • 8.5.4. Latin America immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.5.5.2. Brazil immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.5.5.3. Brazil immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America immunohematology market revenue, by product, 2016-2025 (USD Billion)
        • 8.5.6.2. Rest of Latin America immunohematology market revenue, by application, 2016-2025 (USD Billion)
        • 8.5.6.3. Rest of Latin America immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa immunohematology market, 2016-2025 (USD Billion)
      • 8.6.2. The Middle East and Africa immunohematology market revenue, by product, 2016-2025 (USD Billion)
      • 8.6.3. The Middle East and Africa immunohematology market revenue, by application, 2016-2025 (USD Billion)
      • 8.6.4. The Middle East and Africa immunohematology market revenue, by End-User, 2016-2025 (USD Billion)
  •  
  • Chapter 9. Company Profile
    • 9.1. Thermo Fisher Scientific
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Bio-Rad Laboratories
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. IMMUNOCOR Inc.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Siemens Healthineers
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Ortho Clinical Diagnostics
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. Grifols
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Beckman Coulter
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. Becton, Dickinson and Company
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Abbott Laboratories
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Merck
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global immunohematology market revenue, 2016–2025 (USD Billion) 
4. Porter’s Five Forces Analysis
5. Immunohematology market attractiveness analysis, by product
6. Immunohematology market attractiveness analysis, by application
7. Immunohematology market attractiveness analysis, by End-User
8. Immunohematology market: market attractiveness analysis, by region
9. Company market share analysis, 2018
10. Global immunohematology market revenue share by product, 2018 and 2025
11. Global immunohematology market for immunohematology analyzer, 2016–2025 (USD Billion)
12. Global immunohematology market for immunohematology reagents, 2016–2025 (USD Billion)
13. Global immunohematology market revenue share by application, 2018 and 2025
14. Global immunohematology market for blood typing, 2016–2025 (USD Billion)
15. Global immunohematology market for antibody screening, 2016–2025 (USD Billion)
16. Global immunohematology market for others, 2016–2025 (USD Billion)
17. Global immunohematology market revenue share by End-User, 2018 and 2025
18. Global immunohematology market for academic and research institutes, 2016–2025 (USD Billion)
19. Global immunohematology market for hospitals, 2016–2025 (USD Billion)
20. Global immunohematology market for diagnostics & reference laboratories, 2016–2025 (USD Billion)
21. Global immunohematology market for blood banks, 2016–2025 (USD Billion)
22. Global immunohematology market revenue share by region, 2018 and 2025
23. North America immunohematology market, 2016–2025 (USD Billion)
24. Europe immunohematology market, 2016–2025 (USD Billion)
25. Asia Pacific immunohematology market, 2016–2025 (USD Billion)
26. Latin America immunohematology market, 2016–2025 (USD Billion)
27. The Middle East and Africa immunohematology market, 2016–2025 (USD Billion)
 


Table Of Tables

List of Tables

1. Global immunohematology market: Market Snapshot
2. Drivers of the global immunohematology market: Impact analysis 
3. Restraints of the global immunohematology market: Impact analysis  
4. North America immunohematology market revenue, by product, 2016–2025 (USD Billion)
5. North America immunohematology market revenue, by application, 2016–2025 (USD Billion)
6. North America immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
7. The U.S. immunohematology market revenue, by product, 2016–2025 (USD Billion)
8. The U.S. immunohematology market revenue, by application, 2016–2025 (USD Billion)
9. The U.S. immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
10. Canada immunohematology market revenue, by product, 2016–2025 (USD Billion)
11. Canada immunohematology market revenue, by application, 2016–2025 (USD Billion)
12. Canada immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
13. Europe immunohematology market revenue, by product, 2016–2025 (USD Billion)
14. Europe immunohematology market revenue, by application, 2016–2025 (USD Billion)
15. Europe immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
16. UK immunohematology market revenue, by product, 2016–2025 (USD Billion)
17. UK immunohematology market revenue, by application, 2016–2025 (USD Billion)
18. UK immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
19. Germany immunohematology market revenue, by product, 2016–2025 (USD Billion)
20. Germany immunohematology market revenue, by application, 2016–2025 (USD Billion)
21. Germany immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
22. France immunohematology market revenue, by product, 2016–2025 (USD Billion)
23. France immunohematology market revenue, by application, 2016–2025 (USD Billion)
24. France immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
25. Rest of Europe immunohematology market revenue, by product, 2016–2025 (USD Billion)
26. Rest of Europe immunohematology market revenue, by application, 2016–2025 (USD Billion)
27. Rest of Europe immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
28. Asia Pacific immunohematology market revenue, by product, 2016–2025 (USD Billion)
29. Asia Pacific immunohematology market revenue, by application, 2016–2025 (USD Billion)
30. Asia Pacific immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
31. China immunohematology market revenue, by product, 2016–2025 (USD Billion)
32. China immunohematology market revenue, by application, 2016–2025 (USD Billion)
33. China immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
34. Japan immunohematology market revenue, by product, 2016–2025 (USD Billion)
35. Japan immunohematology market revenue, by application, 2016–2025 (USD Billion)
36. Japan immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
37. India immunohematology market revenue, by product, 2016–2025 (USD Billion)
38. India immunohematology market revenue, by application, 2016–2025 (USD Billion)
39. India immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
40. Rest of Asia Pacific immunohematology market revenue, by product, 2016–2025 (USD Billion)
41. Rest of Asia Pacific immunohematology market revenue, by application, 2016–2025 (USD Billion)
42. Rest of Asia Pacific immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
43. Latin America immunohematology market revenue, by product, 2016–2025 (USD Billion)
44. Latin America immunohematology market revenue, by application, 2016–2025 (USD Billion)
45. Latin America immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
46. Brazil immunohematology market revenue, by product, 2016–2025 (USD Billion)
47. Brazil immunohematology market revenue, by application, 2016–2025 (USD Billion)
48. Brazil immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
49. Rest of Latin America immunohematology market revenue, by product, 2016–2025 (USD Billion)
50. Rest of Latin America immunohematology market revenue, by application, 2016–2025 (USD Billion)
51. Rest of Latin America immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
52. The Middle East and Africa immunohematology market revenue, by product, 2016–2025 (USD Billion)
53. The Middle East and Africa immunohematology market revenue, by application, 2016–2025 (USD Billion)
54. The Middle East and Africa immunohematology market revenue, by End-User, 2016–2025 (USD Billion)
 

Methodology

Free Analysis

Immunohematology is the study of antibodies and RBC antigens that are mainly associated with blood transfusion. The basic principle of immunohematology is the reaction between antigens and antibodies, which either causes hemolysis or RBC agglutination. This is used to detect the presence of a particular antigen in the blood.

As per the NCBI, about 250,000 children suffer from sickle cell anemia every year. According to the CDC, about 100,000 people in the U.S. suffer from sickle cell disease, which is likely to increase in the upcoming years. This growing prevalence of blood-related diseases, such as sickle cell disease, is leading to an increase in the demand for blood transfusion procedures. This, in turn, is fueling the global immunohematology market. Additionally, the prevalence of blood cancer is also driving the global immunohematology market, as it requires blood transfusion frequently. Moreover, the increase in accidents worldwide, rise in the number of blood banks and diagnostics centers in developing countries, new product launches for immunohematology, and growth in government funding are further propelling the immunohematology market globally. However, the high cost of analyzers and reagents and the dearth of skilled professionals may limit the global immunohematology market growth.

Global Immunohematology Market

The global immunohematology market is divided into product, application, and end-user. Based on products, the immunohematology market is divided into immunohematology analyzers and immunohematology reagents. Immunohematology reagents are anticipated to dominate the market in the future, owing to the increase in research activities and growth in the use of customized reagents for research and diagnostic purposes. The application segment of the immunohematology market includes blood typing, antibody screening, and others. Antibody screening dominated the market in 2018, owing to its increased use for blood transfusion. On the basis of end-user, the market includes blood banking, diagnostics and reference laboratories, hospitals, and academic and research institutes.

North America is projected to dominate the global immunohematology market in the years ahead, owing to the early introduction of highly developed techniques, the presence of a highly skilled workforce, and availability of advanced healthcare infrastructure. The Asia Pacific region is anticipated to be the most lucrative market for immunohematology in the upcoming years, owing to the rising investments and funding by government, the establishment of blood banks and trauma centers in India and China, presence of a large patient pool, and increasing accidents in the region.

Some major players of the global immunohematology market are Thermo Fisher Scientific, Bio-Rad Laboratories, IMMUNOCOR, Siemens Healthineers, Ortho Clinical Diagnostics, Grifols, Beckman Coulter, Becton, Dickinson and Company, Abbott Laboratories, and Merck.

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • paypal
  • amazon
  • visa
  • master card

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed